Acceleron Pharma, Inc., A Wholly-owned Subsidiary Of Merck & Co., Inc., Rahway, Nj Usa

This study tested whether adding the drug sotatercept to standard treatments could help people with severe pulmonary arterial hypertension (PAH), a life-threatening lung disease. It involved 173 participants with advanced PAH who were at high risk of death. Researchers compared s…